Last reviewed · How we verify
Unitrim (BRODIMOPRIM)
At a glance
| Generic name | BRODIMOPRIM |
|---|---|
| Drug class | brodimoprim |
| Target | Bifunctional dihydrofolate reductase-thymidylate synthase, Dihydrofolate reductase |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Unitrim CI brief — competitive landscape report
- Unitrim updates RSS · CI watch RSS